首页> 美国卫生研究院文献>The Journal of Physiology >GABAB receptor activation desensitizes postsynaptic GABAB and A1 adenosine responses in rat hippocampal neurones
【2h】

GABAB receptor activation desensitizes postsynaptic GABAB and A1 adenosine responses in rat hippocampal neurones

机译:GABA B受体激活使大鼠海马神经元的突触后GABA B和A1腺苷反应减敏

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Whole-cell recordings of EPSCs and G-protein-activated inwardly rectifying (GIRK) currents were made from cultured hippocampal neurones to determine the effect of long-term agonist treatment on the presynaptic and postsynaptic responses mediated by GABAB receptors (GABABRs). GABABR-mediated presynaptic inhibition was unaffected by agonist (baclofen) treatment for up to 48 h, and was desensitized by about one-half after 96 h. In contrast, GABABR-mediated GIRK currents were desensitized by a similar amount after only 2 h of agonist treatment. In addition, presynaptic inhibition mediated by A1 adenosine receptors (A1Rs) was unaffected by prolonged GABABR activation, whereas A1R-mediated GIRK currents were desensitized. Desensitization of postsynaptic GABABR and A1R responses was blocked by the GABABR antagonist (1-(S)-3,4-dichlorophenylethyl)amino-2-(S) hydroxypropyl-p-benzyl-phosphonic acid (CGP 55845A), but not by the A1R antagonist cyclopentyldipropylxanthine (DPCPX). GIRK current amplitude could be partially restored after baclofen treatment by either coapplication of baclofen and adenosine, or intracellular infusion of the non-hydrolysable GTP analog 5′-guanylylimidodiphosphate (Gpp(NH)p). Short-term (4–24 h) baclofen treatment also significantly desensitized the inhibition of postsynaptic voltage-gated calcium channels by activation of GABABRs or A1Rs. These results show that responses mediated by GABABRs and A1Rs desensitize differently in presynaptic and postsynaptic compartments, and demonstrate the heterologous desensitization of postsynaptic A1R responses.
机译:从培养的海马神经元对EPSC和G蛋白激活的内向整流(GIRK)电流进行全细胞记录,以确定长期激动剂治疗对GABAB受体(GABABR)介导的突触前和突触后反应的影响。 GABABR介导的突触前抑制在长达48小时内不受激动剂(巴洛芬)的影响,在96小时后约有一半被脱敏。相比之下,仅在激动剂治疗2小时后,GABABR介导的GIRK电流就会以相似的量脱敏。此外,由A1腺苷受体(A1Rs)介导的突触前抑制不受延长的GABABR激活的影响,而A1R介导的GIRK电流则不敏感。 GABABR拮抗剂(1-(S)-3,4-二氯苯基乙基)氨基-2-(S)羟丙基-对苄基膦酸(CGP 55845A)阻止了突触后GABABR和A1R反应的脱敏。 A1R拮抗剂环戊基二丙基黄嘌呤(DPCPX)。通过联合应用巴氯芬和腺苷,或在细胞内输注不可水解的GTP类似物5'-鸟苷脂二磷酸(Gpp(NH)p),可以在巴氯芬治疗后部分恢复GIRK电流幅度。短期(4-24小时)巴氯芬治疗还通过激活GABABRs或A1Rs使对突触后电压门控钙通道的抑制作用大大降低。这些结果表明,由GABABR和A1R介导的应答在突触前和突触后区室中的脱敏程度不同,并证明了突触后A1R应答的异源脱敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号